BWA
BSX icon

Basecamp Wealth Advisors’s Boston Scientific BSX Stock Holding History

Basecamp Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
3,977
+237
+6% +$12.9K 0.03% 294
2026
Q1 		$235K Buy
3,740
+1,170
+46% +$93.6K 0.05% 223
2025
Q4 		$245K Buy
+2,570
New +$252K 0.05% 198

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Basecamp Wealth Advisors's BSX Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Boston Scientific (BSX) stake by 6.3% in Q2 2026, buying an estimated $12.9K and bringing the position to 3,977 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #294.

Basecamp Wealth Advisors first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $245K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Basecamp Wealth Advisors held 3,977 shares of Boston Scientific worth $170K as of Q2 2026.
  • Basecamp Wealth Advisors bought 237 Boston Scientific shares in Q2 2026, an estimated $12.9K.
  • Boston Scientific made up 0.03% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #294 holding.
  • Basecamp Wealth Advisors first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Boston Scientific position peaked at $245K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.